Partner Institutions

ICGC Breast Cancer Project: Triple Negative/Lobular/Other is a research collaboration whose article contributions are accrued to its participating partner institutions below.

• The University of Queensland (UQ), Australia
• BC Cancer Agency (BCCA), PHSA, Canada
• Curie Institute, France
• French National Cancer Institute (INCa), France
• IRCCS National Cancer Institute (INT) Bari, Italy
• Erasmus University Rotterdam (EUR), Netherlands
• Academic Medical Center (AMC), UvA, Netherlands
• Radboud University Nijmegen (RU), Netherlands
• Oslo University Hospital (OUS), Norway
• University of Tromsø - The Arctic University of Norway (UiT), Norway
• Singapore General Hospital (SGH), Singapore
• Lund University (LU), Sweden
• King's College London (KCL), United Kingdom (UK)
• Cancer Research UK (CRUK), United Kingdom (UK)
• Institute of Cancer Research (ICR), United Kingdom (UK)
• Wellcome Trust Sanger Institute, United Kingdom (UK)
• Dana-Farber Cancer Institute (DFCI), United States of America (USA)
• International Cancer Genome Consortium (ICGC), International